- 专利标题: Cross-linked glycopeptide-cephalosporin antibiotics
-
申请号: US10888849申请日: 2004-07-09
-
公开(公告)号: US07067482B2公开(公告)日: 2006-06-27
- 发明人: Paul R. Fatheree , Martin S. Linsell , Daniel Marquess , Sean G. Trapp , Edmund J. Moran , James B. Aggen
- 申请人: Paul R. Fatheree , Martin S. Linsell , Daniel Marquess , Sean G. Trapp , Edmund J. Moran , James B. Aggen
- 申请人地址: US CA South San Francisco
- 专利权人: Theravance, Inc.
- 当前专利权人: Theravance, Inc.
- 当前专利权人地址: US CA South San Francisco
- 代理商 Jeffrey A. Hagenah
- 主分类号: A61K38/16
- IPC分类号: A61K38/16
摘要:
This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
公开/授权文献
- US20050026818A1 Cross-linked glycopeptide-cephalosporin antibiotics 公开/授权日:2005-02-03
信息查询
IPC分类: